These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory. Schmidt M J Altern Complement Med; 2003 Apr; 9(2):183-7; author reply 187-8. PubMed ID: 12804070 [No Abstract] [Full Text] [Related]
11. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? Teschke R; Wolff A Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865 [TBL] [Abstract][Full Text] [Related]
13. Kava Hepatotoxicity: Are we any closer to the truth? Anke J; Ramzan I Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493 [TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2012 Mar; (571):1-186. PubMed ID: 22441424 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the safety of kava extract in the treatment of anxiety. Stevinson C; Huntley A; Ernst E Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028 [TBL] [Abstract][Full Text] [Related]
17. [Review "Kava, kavapyrones and toxic liver injury" by R Teschke, Hanau Zeitschrift für Gastroenterologie 2003, 41:395-404]. Stickel F; Seitz HK; Schuppan D Z Gastroenterol; 2003 Aug; 41(8):888-9. PubMed ID: 12910431 [No Abstract] [Full Text] [Related]